Board of Directors and CEO

Board of Directors

Kurt Nilsson
Chairman of the board.
Member of the board since 1996.
Born 1953. Founder of Glycorex Transplantation AB and R&D Manager. Doctor of Engineering in chemistry and applied biochemistry at Lund University. Senior lecturer in biotechnology.
Shareholding including related parties: 3,268,000 A restricted shares and 3,979,051 B unrestricted shares. 

Christer Ahlberg
Member of the board since 2020.
Born 1971.
Christer holds a Master of Science in Business Administration with a degree from Örebro University. Executive President and CEO of Cinclus Pharma since June 2021. Previous experience from the pharmaceutical industry, most recently as President and CEO of Sedana Medical (2017-2021), CEO of the Unimedic Group (2010 – 2016) and CEO of Eisai AB (2005 –2010) as well as more than 10 years of experience in leading positions in sales, Marketing and Market Access in the pharmaceutical industry, among other things astraZeneca, Meda. Chairman of the Board of PharmaControl MQL AB.
Other ongoing assignments: Board member of PMD Solutions AB, FrostPharma AB, Prooxpharma AB. CEO and deputy board member of Waxholm by the sea aktiebolag.
Shareholding: 60,000 Class B shares.
Shareholding: 60,000 B unrestricted shares.

Nils Siegbahn 
Member of the board since 2021 (member and chairman of the company 2000-2009).
Born 1953.
Doctor of Technology in Chemistry and Applied Biochemistry at Lund University and M.Sc in Business and Economics at Stockholm School of Economics. Experience in research, former Marketing Director at Nicoretteand, CEO of several PerstorpB companies, Atos Medical, Pernovo, Alligator Bioscience and Niconovum. Management consultant at ACH Consultant (ongoing). Member of Sparbanksstiftelsen Syd Riskkapitalstyrelse, Celltrix AB and CanImGudie
Shareholding: 0 shares

Leni von Bonsdorff
Member of the board since 2021.
Born 1962.
PhD and EMBA with long experience in the plasma-derived medicine field in R&D, marketing and sales as well as leadership at among others Finnish Red Cross Blood Transfusion and Sanquin. Currently Executive Director at the International Plasma and Fractionation Association. Several positions of trust within technology academies in Finland. 
Shareholding: 0 shares

Torbjörn Axelsson
Member of the board since 2021.
Born 1960. Business and Economics at Lund University with more than 30 years of experience from various positions in economics and finance in several different industries, most recently as CFO at Bona AB.
Shareholding: 0 shares


Tomas Westergren
Deputy member of the board since 2012.
Born 1964.
Master of Engineering, physician and doctor of philosophy in biochemistry, experience of research and clinical work with patients.
Shareholding: 0 shares


Geert Nygaard  
Born 1960.

B.Sc. Chemical Engineering Technical University of Denmark.
Over 30 years of experience in the diagnostics and life science markets from a variety of senior leadership roles with Abbott Laboratories, TECAN, Epigenomics and DAKO.  
Shareholding: 100,000 shares.



Ola Larsmon
Auditor since 2020.
Authorized public accountant, Ernst & Young AB

Stefan Svensson
Deputy auditor since 2017.
Authorized public accountant, Ernst & Young AB

Scheelevägen 27 | SE-223 63 Lund, Sweden

Phone: +46 46 286 52 30  | Fax: +46 46-286 52 39
E-mail: 556519-7372

© 2021 Glycorex Transplantation AB. Registered office in Lund, Sweden . All rights reserved.